Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abivax SA | Paris | Healthcare | Biotechnology & Medical Research | €602.46M | -3x | -1.92 | €9.57 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Valneva | Paris | Healthcare | Biotechnology & Medical Research | €421.84M | -10.9x | 0.04 | €2.58 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Genfit | Paris | Healthcare | Biotechnology & Medical Research | €267.16M | 12x | 0.07 | €5.34 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Eurobio Scientific | Paris | Healthcare | Biotechnology & Medical Research | €258.62M | 42.8x | -1.74 | €25.70 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 17% Upside | Upgrade to Pro+ | |
Ose Pharma International SA | Paris | Healthcare | Biotechnology & Medical Research | €216.45M | 4.6x | 0.02 | €9.92 | -3.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 27.2% Upside | Upgrade to Pro+ | |
Inventiva | Paris | Healthcare | Biotechnology & Medical Research | €212.47M | -1.2x | 0.24 | €2.44 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sensorion SA | Paris | Healthcare | Biotechnology & Medical Research | €210.25M | -6.7x | -0.14 | €0.70 | 2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nanobiotix | Paris | Healthcare | Biotechnology & Medical Research | €183.46M | -5x | -0.1 | €3.87 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cellectis | Paris | Healthcare | Biotechnology & Medical Research | €169.16M | -1.8x | -0.05 | €1.70 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Innate Pharma | Paris | Healthcare | Biotechnology & Medical Research | €155.29M | -3.9x | -0.09 | €1.63 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Adocia | Paris | Healthcare | Biotechnology & Medical Research | €132.55M | -5.8x | -0.21 | €8.62 | -5.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -28.7% Downside | Upgrade to Pro+ | |
Transgene | Paris | Healthcare | Biotechnology & Medical Research | €122.22M | -4.1x | -0.16 | €0.92 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Maat Pharma | Paris | Healthcare | Biotechnology & Medical Research | €102.44M | -3.7x | 0.09 | €7.48 | 1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Eurofins-Cerep | Paris | Healthcare | Biotechnology & Medical Research | €97.35M | 9.9x | €19,300 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Abionyx Pharma SA | Paris | Healthcare | Biotechnology & Medical Research | €47.02M | -12.4x | -0.56 | €1.39 | 2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Novacyt | Paris | Healthcare | Biotechnology & Medical Research | €45.15M | -1x | 0.02 | €0.64 | -2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Gensight Biologics | Paris | Healthcare | Biotechnology & Medical Research | €33.25M | -1x | -0.03 | €0.31 | -1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 12.5% Upside | Upgrade to Pro+ | |
Genoway | Paris | Healthcare | Biotechnology & Medical Research | €30.82M | 22.7x | €3.42 | 1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Fermentalg | Paris | Healthcare | Biotechnology & Medical Research | €28.98M | -1.3x | 0.14 | €0.34 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
NFL Biosciences | Paris | Healthcare | Biotechnology & Medical Research | €20.62M | €2.06 | -3.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Oncodesign Precision Medicine | Paris | Healthcare | Biotechnology & Medical Research | €19.62M | -2.3x | €1.09 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Valbiotis | Paris | Healthcare | Biotechnology & Medical Research | €19.38M | -2.1x | €1.24 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Phaxiam Therapeutics | Paris | Healthcare | Biotechnology & Medical Research | €18.24M | -0.4x | €1.85 | -3.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Poxel SA | Paris | Healthcare | Biotechnology & Medical Research | €15.45M | -0.3x | -0.15 | €0.28 | -3.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Institut Biophytis SAS | Paris | Healthcare | Biotechnology & Medical Research | €15.08M | -0.5x | -0 | €0.35 | 12.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Plant Advanced Technologies SA | Paris | Healthcare | Biotechnology & Medical Research | €13.74M | -18.7x | €12.50 | -10.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Predilife | Paris | Healthcare | Biotechnology & Medical Research | €13.45M | -3.2x | 0.23 | €3.62 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Acticor Biotech | Paris | Healthcare | Biotechnology & Medical Research | €9.26M | -0.3x | -0.01 | €0.44 | -24.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
TME Pharma NV | Paris | Healthcare | Biotechnology & Medical Research | €5.82M | -0.4x | -0.01 | €0.14 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Quantum Genomics SA | Paris | Healthcare | Biotechnology & Medical Research | €5.03M | -0.8x | -0.02 | €0.07 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 38.7% Upside | Upgrade to Pro+ |